SWX:SDZ
SWX:SDZPharmaceuticals

Sandoz Group (SWX:SDZ) Valuation Check After EU Approval For Ondibta Biosimilar Insulin

Sandoz Group (SWX:SDZ) is back in focus after the European Commission granted marketing authorization for Ondibta, a biosimilar insulin glargine that could widen diabetes treatment options across Europe from early 2027. See our latest analysis for Sandoz Group. The Ondibta news lands after a strong 90 day share price return of 27.17% and a 1 year total shareholder return of 49.84%, suggesting momentum has been building around Sandoz Group, despite a 1 day share price return decline of 0.75%...
SWX:AVOL
SWX:AVOLSpecialty Retail

A Look At Avolta (SWX:AVOL) Valuation After New Geneva And Palm Beach Airport Concession Wins

Why the Geneva and Palm Beach airport projects matter for Avolta (SWX:AVOL) Avolta (SWX:AVOL) is in focus after announcing a multi-year redevelopment of its food and beverage footprint at Geneva Airport, alongside two 10-year contracts to expand travel retail and dining at Palm Beach International Airport. Together, these projects highlight how the company is leaning into long-duration airport concessions, refreshed concepts, and a broader mix of proprietary and local brands, giving investors...
SWX:VAHN
SWX:VAHNInsurance

European Dividend Stocks To Enhance Your Portfolio

As the European market shows resilience with the STOXX Europe 600 Index rising by 0.77% amid solid economic data and earnings results, investors are increasingly focusing on dividend stocks to bolster their portfolios. In a climate where stability and income generation are highly valued, selecting dividend stocks that align with robust financial performance and consistent payout histories can be a prudent strategy for enhancing investment portfolios.
SWX:VACN
SWX:VACNMachinery

VAT Group (SWX:VACN) Is Up 14.1% After Q4 Order Rebound Signals Renewed Demand Momentum

In January 2026, VAT Group AG reported preliminary results showing fourth-quarter 2025 net sales of CHF 257 million versus CHF 283.2 million a year earlier, and full-year 2025 net sales of CHF 1.07 billion compared with CHF 942.2 million. Despite the softer quarterly sales, fourth-quarter 2025 orders climbed to about CHF 305 million, rising both sequentially and year on year, highlighting a renewed pickup in demand that contrasts with the more muted full-year order trend. We will now...
SWX:SIKA
SWX:SIKAChemicals

A Look At Sika (SWX:SIKA) Valuation After 2025 Sales Miss And Margin Guidance Cut

Sika (SWX:SIKA) is back in focus after its 2025 trading update showed weaker sales, a lower profit margin outlook, and a sharp share price reaction as investors reassess regional and currency risks. See our latest analysis for Sika. The recent 2025 trading update and guidance cut come on top of a weaker share price trend, with a 90 day share price return of 14.17% and a 1 year total shareholder return of 32.05%. This points to fading momentum as investors reassess regional and currency...
SWX:COPN
SWX:COPNPharmaceuticals

Assessing Cosmo Pharmaceuticals (SWX:COPN) Valuation After Vision 2030 Scale Up And AI Healthtech Expansion

Why Cosmo Pharmaceuticals is Back on Investors’ Radars Cosmo Pharmaceuticals (SWX:COPN) is drawing fresh attention after management detailed a scale up phase under its Vision 2030 plan, highlighting solid finances, expanding GI Genius and Winlevi franchises, and a maturing dermatology and gastroenterology pipeline. See our latest analysis for Cosmo Pharmaceuticals. That story around Vision 2030 seems to be resonating with the market, with a 90 day share price return of 75.23% and a 1 year...
SWX:BAER
SWX:BAERCapital Markets

Do Julius Bär (SWX:BAER) Leadership Changes Clarify or Complicate Its Transformation Story?

Julius Bär Gruppe has announced past and upcoming organisational and leadership changes, appointing former HSBC executive Jean Nabaa as COO while current COO and Deputy CEO Nic Dreckmann plans to step down by April 2026, alongside the creation of a new Group Communications function to be led by experienced communicator Cindy Leggett-Flynn. By bringing in leaders with extensive international wealth management and high-stakes communications experience, Julius Bär is signaling a push to...